Quality & Patient Safety

Rapid approval process broken, says congressman

Patient Safety Monitor Alert, June 2, 2005

Want to receive articles like this one in your inbox? Subscribe to Patient Safety Monitor Alert!

The Food and Drug Administration's new rapid approval process for new drugs may harm patients because of a lack of oversight, according to a Reuters report.

Congressman Ed Markey (D-MA) said the drug companies are not completing required follow-up studies and the FDA is not double-checking to see that work is done. The result is a lax system which may allow unsafe drugs onto the market, Markey said.

Officials at the FDA said the process is instrumental in getting helpful drugs on the market. Pharmaceutical companies point to the low rate of recall on drugs as proof that the system is safe.

To read the complete article, click here.



Want to receive articles like this one in your inbox? Subscribe to Patient Safety Monitor Alert!

    Patient Safety Monitor
  • Patient Safety Monitor

    As part of your Patient Safety Monitor membership, you'll receive Briefings on Patient Safety. In this 12-page monthly...

  • Patient Safety Monitor Alert

    This e-mail newsletter provides healthcare professionals with the latest patient safety news, while offering useful...

  • Patient Safety Quality Monthly

    Ken Rohde, Senior Consultant for The Greeley Company with over 25 years of experience in quality management. His roles in...

  • Occurrence Reporting:

    Take advantage of the information occurrence reports provide and make sustainable enhancements at your facility. Expert...

Most Popular

Related Articles